Liraglutide
A synthetic acylated analog of glucagon-like peptide-1 (GLP-1).
Observed median price
$0
0
Active listings
0
Independent lab tests
No active listings
Observed price range
4
Known aliases
Understand this compound
What is Liraglutide?
FDA-approved moleculea.k.a. Saxenda, VictozaAn earlier daily GLP-1 analog (Victoza/Saxenda) studied in metabolic and weight research.
Good to know: Requires daily injection (shorter-acting than newer weekly agents); labeling notes GI effects and rare pancreatitis/thyroid C-cell tumor signals from animal studies.
How does Liraglutide work?
A GLP-1 receptor agonist with 97% sequence homology to native GLP-1; stimulates insulin secretion, suppresses glucagon, slows gastric emptying, and promotes satiety.
Mechanism of action from published research — how the molecule behaves, not a claim about any product or any human-use effect.
What is Liraglutide researched for?
Studied for type-2 diabetes and chronic weight management (obesity), including in pediatric populations.
- Weight & metabolicStudied in weight, appetite, blood-sugar, and fat-metabolism research.
How far has the research gone?
FDA-approved (for type-2 diabetes and obesity); approved as Victoza (2010) and Saxenda (2014).
Where the science stands — an approved drug is not the same as the research-grade material a vendor sells, which is unregulated regardless.
What should I check before buying?
- Independent purity. Look for a third-party COA (Janoshik or MZ) showing a measured purity — not just a number the vendor typed.
- Batch match. The strongest evidence is a certificate for the exact batch you’ll receive, attributed to this vendor — check the cross-verification on the listing.
- Vendor reputation. See how the vendor is talked about in the community before trusting a new name.
Research context only — VialGrade never gives dosing, medical, or human-use guidance.
This is a prescription drug in the US
This is the active drug in Victoza and Saxenda — an FDA-approved prescription medication. Buying a “research” version sidesteps the prescription requirement and the approved, quality-controlled supply chain. The FDA has warned about and acted against unapproved and compounded copies. Higher legal and safety exposure than an unapproved research peptide.
Read the full US legal overview →General information, not legal or medical advice. VialGrade sells nothing and encourages no human use.
Current market
All Liraglutide listings
Research notes aren’t product proof
Research summaries describe published literature and market data only. They do not establish the identity, quality, safety, or legal status of any listed physical product.